Recent Articles

• 
  Medical / Drug Development

  Drug Candidate KLS-3021 to Broaden Uses by 2031

  Kolon Life Science headquarters. Kolon Life Science stated on the 23rd that it plans to add indications for its new drug candidates KLS-3021 and KLS-2031 and strengthen the foundation for global commercialization. Provided by Kolon Life Science Kolon Life Science stated on the 23rd that it plans to

  2026.02.25
• 
  Pharmaceutical R&D

  AI Aging Prediction, mRNA Vaccines: ‘R&D First’ Push

  Researchers at Korea University Medical Center wearing protective suits conduct research in a laboratory. The role of university hospitals no longer stops at treatment and education. Addressing problems encountered in clinical settings through research and then linking this to technology and industr

  2026.02.25
• 
  Healthcare / Sleep Tech

  Slipwave Aims to Be Pacemaker of Deep Sleep

  [ITDongA x Korea University] Korea University operates the “Crimson Startup Support Group,” a startup founding and incubation organization under the direct supervision of the Vice President for Research. It introduces promising startups affiliated with Korea University that are growing together with

  2026.02.24
• 
  Clinical Trial

  DongKoo Bio Completes Phase 3 Trial of Prostate Cancer Drug

  DongKook Pharmaceutical announced on the 24th that it has successfully completed a Phase 3 clinical trial for its long-acting prostate cancer injectable treatment “Lorelin Depot Injection (ingredient name: leuprorelin)” in a 3‑month formulation (DKF-MA102).The new 3‑month formulation injection was d

  2026.02.24
• 
  Biopharma / Celltrion

  Celltrion Targets Obesity Drugs With Dual GLP-1 Strategy

  Celltrion Celltrion is moving into the obesity treatment market. The company plans to develop new drugs with differentiated competitiveness and establish its position in the market.Celltrion announced on the 24th that it will pursue the development of obesity treatments through a two-track strategy:

  2026.02.24
• 
  Global Expansion

  Huons Meditech, India’s Vasu Group Hold CKD Line Completion Ceremony

  Huons Group Chairman Yoon Sung-tae (right) and Vasu Group CEO Abhinay Bezgam (left) are holding the completion ceremony for the local assembly production line. Provided by Huons Meditech Huons Meditech, the medical device specialist of Huons Group, announced on the 24th that it held a completion cer

  2026.02.24
• 
  Medical / Drug Development

  GC Cell Patents Core Allogeneic Cell Therapy Technology

  GC Cell announced on the 24th that it has completed patent registrations in Korea and Japan for core fundamental technologies for the development of next-generation cell and gene therapies.The patent covers a technology that controls Class II MHC Transcription Activator (CIITA), a key gene that regu

  2026.02.24
• 
  Medical / Drug Development

  AI Finds Salmonella Predator, Stronger Than Antibiotics

  Dong-A DB One of the causes of colitis, Salmonella bacteria, can be suppressed by a newly discovered substance. The National Marine Biodiversity Institute of Korea (Honam Regional Office) announced that a new peptide had been discovered in a study conducted with the College of Pharmacy at Chonnam Na

  2026.02.24
• 
  Global Expansion

  Cosmax Secures First Production Base in Europe

  Cosmax, an original design manufacturer (ODM) of cosmetics, has acquired an Italian cosmetics company and secured its first production base in Europe. The company plans to further strengthen its dominance in the global market through this move.Cosmax announced on the 23rd that it has signed a share

  2026.02.24
• 
  AI Healthcare

  Daewoong Pharma Launches Digital Health Monitoring Era

  Park Hyung-chul, Head of ETC Marketing Division, Daewoong Pharmaceutical Daewoong Pharmaceutical has announced its plan to establish a “24-hour nationwide health monitoring system” that connects hospitals and homes. The company also presented a concrete roadmap to expand its next-generation smart be

  2026.02.23